You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Justin Petrone covers consumer genomics, ancestry testing, and the microarray and biochip sector of the genomics market for GenomeWeb.
The Solna, Sweden-based company is currently expanding from offering in situ sequencing services to selling kits.
Technology partners on the study include BioMérieux and SkylineDx, as well as Imperial College London's biomedical electronics unit.
Some of the market's most influential voices, including Kári Stefánsson and Linda Avey, believe that consumer genomics is not on the way out but rather experiencing a period of transition.
The company believes cytogeneticists will adopt its panel to get high-quality SNV and CNV data in a single assay.
The company hopes to help consumer genomics firms and healthcare companies reduce the IT burdens associated with launching a new test.
As 2020 dawns, forensic genomics is poised for growth as companies aim to harness the power of consumer databases coupled with advances in sequencing.
Using the free service, called Fingenious, researchers will be able to access genomic data generated by the country's FinnGen project, which aims to genotype 500,000 Finns by 2023.
Led by investigators at the University of Oslo, the four-year CoMorMent project is slated to commence next month with a total budget of €6 million.
The British molecular diagnostics company received a CE-IVD mark for the assay, called BCA-1, in June, and launched the test in October.
After comparing manual methods with the firm's pcr.ai tool in more than 20,000 cases, they found that the use of AI improved test accuracy and reliability.
Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.
Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.
The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.
In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.